corner
Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Healthy Skepticism Library item: 6800

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

 

Publication type: Journal Article

Valpy M.
Science friction
Elm Street 1998; 26-28, 30, 32, 34-36


Abstract:

A detailed account about the battle between Dr. Nancy Olivieri, Apotex, the Hospital for Sick Children and the University of Toronto around the drug deferiprone. Olivieri was doing research on this product for Apotex, when she became concerned that the drug was causing liver damage. When she tried to take her concerns to Apotex she was threatened with legal action. Both the Hospital for Sick Children and the University of Toronto refused to support her.

Keywords:
*feature story/Canada/Apotex/Hospital for Sick Children/University of Toronto/ deferiprone/ drug company sponsored research/ disinformation/ intimidation/ reaction to critics/ relationship between researchers, academic institutions and industry/ETHICAL ISSUES IN PROMOTION: ETHICS OF TRIALS/ETHICAL ISSUES IN PROMOTION: LINKS BETWEEN HEALTH PROFESSIONALS AND INDUSTRY/SPONSORSHIP: RESEARCH

 

  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Please
Click to Register

(read more)

then
Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts


If there is something you don't like, please tell us. If you like our work, please tell others.

Email a Friend








What these howls of outrage and hurt amount to is that the medical profession is distressed to find its high opinion of itself not shared by writers of [prescription] drug advertising. It would be a great step forward if doctors stopped bemoaning this attack on their professional maturity and began recognizing how thoroughly justified it is.
- Pierre R. Garai (advertising executive) 1963